期刊文献+

新型汉防己甲素纳米微球的制备及性质研究 被引量:7

Novel nanoparticles of tetradrine:preparation and properties
下载PDF
导出
摘要 目的:以自行合成的mPEG-PCL(单甲氧基聚乙二醇-聚己内酯)为原料,制备负载汉防己甲素的高分子纳米微球,并全面考察其性质。方法:通过开环聚合法,制备mPEG-PCL两嵌段聚合物,采用优化的o/w乳化扩散/挥发法,制备负载汉防己甲素的纳米粒子。优化制备工艺并考察载体的结构、分子量,纳米粒子的形态、粒径分布、体外释药特性等性质。结果:通过开环聚合法合成mPEG-PCL两嵌段聚合物,测定分子量和设计分子量相近。通过乳剂-挥发法制备的空白粒子呈规整的球形,在冻干前后的平均粒径为(272.6±3.2)nm及(285.8±4.2)nm,载药粒子在冻干前后的粒径分别为(281.5±3.8)nm及(287.6±6.0)nm。汉防己甲素的最高载药量为14.38%。体外释放实验显示,载药粒子具有缓释特征,在6h、12h、48h分别释放48%、58%、71%。结论:本文报道的汉防己甲素载药纳米微球具有一定的缓释特征,具有良好的应用前景和价值。 Objective : To prepare tetradrine (Tet) - loaded nanoparticles with di - block copolymer mPEG - PCL, and evaluate their properties. Methods : mPEG - PCL was synthesized by ring - opening polymerization method and the nanoperticles were prepared by the optimized o/w emulsion - evaporation method. Chemical structure and molecular weight of the copolymer and physical properties of the nanoparticles such as morphology, particle size, drug loadings etc. Were studied comprehensively. Results: mPEG - PCL was synthesized with the desired molecular weight. The nanoparticles are global with good storage stability. The diameter of blank nanoparticles was (272.6 ±3.2 ) nm and (285.8 ± 4.2) nm before and after freeze - dry respectively. The diameter of Tet - loaded nanoparticles was ( 281.5 ± 3.8) nm and (287.6 ~± 6.0 ) nm before and after freeze - dry respectively. The maxium drug loading content was 14.38%. In vitro release study demonstrated the sustained release of Tet from Tet - loaded nanoparticles with the release of 48 % , 58 % and 71% percentage of total drug at 6h, 12h, and 48h, respectively. Conclusion: Tet - loaded nanoparticles reported in the current report showed a good sustained release pattern,which featured it a potential application in cancer treatment.
出处 《现代肿瘤医学》 CAS 2009年第5期798-801,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:30670958)
关键词 汉防己甲素 纳米粒子 药物输送体系 tetradrine nanoparticles drug - delivery system
  • 相关文献

参考文献11

  • 1Tang W, Hemm I, Bertram B. Recent development of antitumor agents from chinese herbal medicines; part Ⅰ. Low molecular compounds[ J]. Planta Med ,2003,69:97 - 108.
  • 2Wei J, Liu B, Wang L, et al. Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent- associated genes in human gastric cancer cell lines[ J]. Cancer Chemother Pharmacol,2007,60:703 - 711.
  • 3Wang G,Lemos JR, Iadecola C. Herbal alkaloid tetrandrine : fron an ion channel blocker to inhibitor of tumor proliferation [ J ]. Trends Pharmacol Sci ,2004,25 : 120 - 123.
  • 4Meng LH, Zhang H, Hayward L, et al. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down - regulating the activity and inducing the degradation of G1 - S - specific cyclin - dependent kinases and by inducing !353 and p21Cip1 [ J ]. Cancer Res ,2004,64:9086 - 9092.
  • 5Langer R. New methods of drug delivery [ J ]. Science, 1990,249 : 1527 - 1533.
  • 6Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long - circulating polymeric nanospheres [ J ]. Science, 1994,263 : 1600 - 1603.
  • 7Zhang L, Hu Y, Jiang X, et al. Carnptothecin derivative - loaded poly( caprolactone - co - lactide) - b - PEG - b - poly ( caprolactone -co -lactide) nanoparticles and their biodistribution in mice[ J]. J Control Release,2004,96 : 135 - 148.
  • 8Tewes F, Munnier E, Antoon B, et al. Comparative study of doxorubicin - loaded poly ( lactide - co - glycolide ) nanopartides prepared by single and double emulsion methods [ J ]. Eur J Pharm Biopharm,2007,66:488 - 492.
  • 9Li W, Chen Z, Liao Y, et al. Separation methods for toxic components in Traditional Chinese Medicines [ J ]. Anal Sci, 2005,21 : 1019 - 1029.
  • 10Haha Y ,Kojima C ,Harada A, et al. Preparation of poly( ethylene glycol) - modified poly( amido amine) dendrimers encapsulating gold nanopartieles and their heat - generating ability [ J ]. Langmuir,2007,23:5243 - 5246.

同被引文献141

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部